Janus Henderson Group PLC Blueprint Medicines Corp Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 28,749 shares of BPMC stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,749
Previous 29,057
1.06%
Holding current value
$2.64 Million
Previous $2.76 Million
12.41%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$609 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$599 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$538 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$297 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$226 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.48B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...